Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS and to the...
46th European Congress of Cytology
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026
UK NEQAS webinar: Introduction to Cellular Components, Tissue Morphology and Tissue Recognition
Online
6-7 October, 2026
Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
8 October, 2026
Microbe 2026
Crowne Plaza Hotel, Sheffield
9-11 October, 2026
UK NEQAS webinar: IHC Technical Issues and Quality Assurance
Online
13-15 October, 2026